Planta Med 2023; 89(14): 1421
DOI: 10.1055/s-0043-1774261
Abstracts
Wednesday 5th July 2023 | Poster Session III
Phytopharmacology III

Exploring the antiviral activity of flavonoids from Strychnos variabilis leaves against SARS-CoV-2

Allison Ledoux
1   University of Liege Faculty of Medicine, CIRM, Building B36 Quartier Hôpital 4000, Liège, Belgium
,
Kristi Leka
1   University of Liege Faculty of Medicine, CIRM, Building B36 Quartier Hôpital 4000, Liège, Belgium
,
Olivia Jansen
1   University of Liege Faculty of Medicine, CIRM, Building B36 Quartier Hôpital 4000, Liège, Belgium
,
Olivier Bonnet
1   University of Liege Faculty of Medicine, CIRM, Building B36 Quartier Hôpital 4000, Liège, Belgium
,
Carla Hamann
1   University of Liege Faculty of Medicine, CIRM, Building B36 Quartier Hôpital 4000, Liège, Belgium
,
Luc Angenot
1   University of Liege Faculty of Medicine, CIRM, Building B36 Quartier Hôpital 4000, Liège, Belgium
,
Mutien-Marie Garigliany
2   University of Liege Faculty of Veterinary Medicine, FARAH, Building B42 Quartier Vallée 2 Avenue de Cureghem 7A-7D 4000, Liège, Belgium
,
Michel Frédérich
1   University of Liege Faculty of Medicine, CIRM, Building B36 Quartier Hôpital 4000, Liège, Belgium
› Author Affiliations
 
 

Strychnos variabilis De Wild. is a small deciduous tree that is primarily distributed in and around Brazzaville and Kinshasa, located on both sides of the Congo River in Africa [1]. While the leaves have only trace amounts of indoline alkaloids (retuline series) [2] [3], our laboratory isolated numerous rare flavonoids, including flavonol glycosides, from the leaves over three decades ago [4] [5] [6]. Flavonoids are known for their antiviral activity, especially when in glycosidic form, which increases their solubility and effectiveness compared to their non- glycosidic forms [7] [8]. Therefore, our present study aims to investigate the potential antiviral activity of S. variabilis leaves against SARS-CoV-2. Our findings revealed that the total extract of S. variabilis exhibits significant antiviral activity with an IC50 range of 12.5 to 6.25 µg/mL. Moreover, we tested two flavonoids, variabilosides C and D [5], which demonstrated even greater potency with an IC50 range of 6.9 to 3.5 µM.

We suggest that the flavonoids present in S. variabilis leaves could provide a promising pathway for the development of a new herbal substrate used as an adjunctive therapeutic in the treatment of coronavirus disease. Further investigation into the pharmacological properties of these flavonoids is thus warranted to fully explore their potential as therapeutic agents against SARS-CoV-2.



Publication History

Article published online:
16 November 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany